The SNP rs961253 in 20p12.3 Is Associated with Colorectal Cancer Risk: A Case-Control Study and a Meta-Analysis of the Published Literature by Zheng, Xiawen et al.
The SNP rs961253 in 20p12.3 Is Associated with
Colorectal Cancer Risk: A Case-Control Study and a Meta-
Analysis of the Published Literature
Xiawen Zheng
1,2., Li Wang
3., Yaowu Zhu
1, Qing Guan
1, Huijun Li
1, Zhigang Xiong
1, Lingyan Deng
1,
Jie Lu
1, Xiaoping Miao
2, Liming Cheng
1*
1Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, 2MOE Key Lab of
Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology,
Wuhan, China, 3Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences; School of Basic Medicine, Peking
Union Medical College, Beijing, China
Abstract
Background: Colorectal cancer (CRC) is the third common cancer and the fourth leading cause of cancer death worldwide.
A single nucleotide polymorphism (SNP), rs961253 located in 20p12, was firstly described to be associated with the
increased risk of CRC in a genome-wide association study; however, more recent replication studies yielded controversial
results.
Methodology/Principal Findings: A hospital-based case-control study in a Chinese population was firstly performed, and
then a meta-analysis combining the current and previously published studies were conducted to explore the real effect of
rs961253 in CRC susceptibility. In the Chinese population including 641 cases and 1037 controls, per-A-allele conferred an
OR of 1.60 (95% CI=1.26–2.02) under additive model. In the meta-analysis including 29859 cases and 29696 controls, per-A-
allele have an OR of 1.13 (95% CI=1.09–1.18) under a random-effects model due to heterogeneity (P=0.019). Nevertheless,
the heterogeneity can be totally explained by ethnicity, with the tau
2reduced to 0 after including ethnicity in meta-
regression model. In stratified analysis by ethnicity, per-A-allele had ORs of 1.34 (95% CI=1.20–1.50) and 1.11 (95%
CI=1.08–1.14) for Asian and European, respectively, without heterogeneity. Modest influence of each study was observed
on overall estimate in sensitive analysis, and evident tendency to significant association was seen in cumulative analysis
over time, together indicating the robust stability of the current results.
Conclusions/Significance: The results from our study and the meta-analysis provided firm evidence that rs961253
significantly contributed to CRC risk in both Asian and European population.
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Introduction
Colorectal cancer (CRC) is the third common malignancy and
the fourth leading cause of cancer mortality in the world, with
more than 1.2 million incidences worldwide each year and
approximately 630,000 death from CRC annually [1]. CRC is a
complex trait influenced by environmental and genetic factors and
their interactions. Analysis of phenotype concordance in twins
reflected the strong genetic component to development of CRC
[2], which is responsible for ,35% of all CRC. Nevertheless, high-
risk germline mutations in a few genes, such as APC, the mismatch
repair (MMR) genes, SMAD4, andBMPR1A, explained ,5% of
total CRC [3]. Growing evidence from epidemiological studies has
invoked the common allele-common disease paradigm in CRC.
Recent genome-wide association (GWA) studies have validated
this hypothesis and implicated multiple common single nucleotide
polymorphisms (SNPs) contributing to CRC susceptibility [4–12].
Among these SNPs, rs961253 (20p12.3), located in proximity of
the gene bone morphogenetic protein 2 (BMP2), was firstly
identified by Houlston et al. to be significantly associated with
CRC risk in the meta-analysis of two GWAS comprising 6780
cases and 6843 controls [5]. BMP2, as a key member of
transforming growth factor-beta (TGF-b) super family, has been
shown to inhibit colonic epithelial cell growth and promote
apoptosis and thus critically involve in development of CRC [13].
However, in the more replication studies results have been
inconsistent [14,15]. In part, the difficulty of replication occurs
potentially due to the modest effect of this SNP, with an odds ratio
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34625(OR) of 1.12 reported for the minor allele; hence, small genetic
association studies have a lack of power and might fail to replicate
this association. Additionally, due to the phenomena ‘‘winner’s
curse’’ that OR of disease variant is usually overestimated in the
initial positive study, the necessary sample size of replication study
would be underestimated if basis on the initially reported OR,
then the replication would be underpowered and possibly fail [16].
Nevertheless, meta-analysis, a statistical tool for combing data
across studies, is powerful to clarify inconsistent findings in genetic
association studies due to its exponential increase in sample size
[17]. Therefore, in this study, we conducted a meta-analysis,
combining results from published literature and our case-control
study herein performed in a Chinese population, to provide a
more precise estimation of the association between rs961253 and
CRC risk.
Materials and Methods
Study population
A total of 641 incident cases of CRC and 1037 controls were
enrolled between 2009 and 2011 from Tongji Hospital of
Huazhong University of Science and Technology (HUST),
Wuhan, China. All of the subjects were unrelated ethnic Han
Chinese in Wuhan region. Cases have been histological confirmed
with primary CRC and had not received treatment prior to blood
samples collection. Controls were cancer-free individuals random-
ly selected from a health check-up program at the same Hospital in
the same period as the cases were enrolled. Controls were
frequency-matched to cases by age (65 years) and gender. At
recruitment, a 5-ml peripheral blood sample was collected from
each subject after written informed consent was obtained. This
study was approved by the Institutional Review boards of Tongji
Hospital of HUST.
Genotyping
Genomic DNA was extracted from 5-mL of peripheral blood
sample using the Relax Gene Blood DNA System DP319-02
(Tiangen, Beijing, China) according to the manufacturer’s
instructions. The genotypes of rs961253 SNP was determined by
the TaqMan SNP Genotyping Assay(Applied Biosystems, Foster
city, CA) using the 7900HT Fast Real-Time PCR System (Applied
Biosystems, Foster city, CA). For quality control, 5% duplicated
samples were randomly selected for to assess the reproducibility,
with a concordance rate of 100%.
Statistical Analysis
The x
2test, Fisher exact test, and t test were applied to estimated
differences in the distribution of demographic characteristics and
genotypes between cases and controls, where appropriate. Hardy-
Weinberg equilibrium (HWE) was assessed by the goodness-of-fit
x
2test for genotypes in the control group. Under multivariate
logistic regression model, the genotypic OR and its 95% CI were
calculated after adjusting for age and sex, with the reference of the
common homozygote. To avoid the assumptions of genetic
models, additive and dominant model for rs961253 in associated
with CRC were also analyzed. All above statistical analysis were
carried out in the SPSS V12.0.
Meta-analysis of rs961253 in association with CRC risk
To confirm the involvement of rs961253 in CRC susceptibility,
a meta-analysis combining published studies and our case-control
study was conducted. We searched the all publications updated to
October of 2011 from the PubMed, EMBASE, and ISI Web of
Science data bases without language restriction, using the search
strategy based on the terms ‘rs961253, BMP2 or 20p12.3’ in
combination with ‘Colorectal neoplasmor colorectal cancer’.
References listed in retrieved articles were also checked for
missing information. The inclusion criteria were: (1) case-control
or nested case-control study assessing the association between
rs961253and CRC risk; (2) providing data for calculating
genotypic odds ratio (ORs) with corresponding 95% confidence
interval (95% CI); (3) genotypes in controls being in Hardy-
Weinberg equilibrium (P.0.01). Animal studies, reviews, simply
commentaries and case reports were excluded. Study overlapping
with other studies should be eliminated, and the one with larger
sample size was selected. If more than one geographic or ethnic
population were included in one report, each population was
considered separately.
The following data were extracted from each study: first
author’s name, year of publication, study design, geographic
location or ethnicity of study population, control source, sample
size, genotyping method, male/female rate, mean age, frequencies
of genotypes in cases and controls. Hardy-Weinberg equilibrium
in controls was estimated again in the meta-analysis by the
goodness-of-fit x
2 test (P.0.01). Pooled frequency of the A allele in
various ethnic populations was estimated using the inverse
variance method previously described by Thakkinstian et al.
[18].ORs and 95% CIs as the metrics of effect size were re-
calculated for the genotypes AA versus CC and CA versus CC. A
dominant genetic model was assumed for the rs961253, and an
additive ‘‘per-allele’’ model was also considered. The per-allele
OR of the A allele was estimated by assigning scores of 0, 1, and 2
to the genotypes CC, CA, and AA, respectively, and calculating
ORs per units score by logistic regression model. Between-study
heterogeneity across all eligible comparisons was estimated by the
Cochran’s Q statistic and the I
2metric. Heterogeneity was
considered significant at P,0.10 for the Q statistic [19]. For the
I
2 metric, the following cut-off points were used: I
2=0–25%, no
heterogeneity; I
2=25–50%,moderate heterogeneity; I
2=50–75%,
large heterogeneity; I
2=75–100%, extreme heterogeneity [20]. A
fixed-effects model, using Mantel-Haenszel method [21], was
applied to pool data from studies when heterogeneity was
negligible based on P for Q statistic greater than 0.1; otherwise,
a random-effects model, using DerSimonian and Laird method
[22], was applied. To explore sources of heterogeneity across
studies, a meta-regression model was employed [23]. The pre-
specified characteristics for assessment of heterogeneity sources
were: ethnicity of population (Asian and European), source of
control (population and hospital based controls), study type
(replication and GWA studies), sample size (#2000 and .2000
subjects) and genotyping method (high-throughput and low-
throughput assays). Stratified analysis was then conducted,
according to the potential sources of heterogeneity reported by
meta-regression analysis. Sensitivity analysis was conducted to
assess influence of each study on overall estimate [24]. Cumulative
analysis was performed by assortment of publication times [25].
Publication bias was assessed by funnel plot [26], Egger’s test [27],
and the trim and fill method [28], which estimates the number and
outcomes of potentially missing studies resulting from publication
bias. All statistical analyses were carried out in STATA V11.0, and
all P values are two-tailed with a significant level at 0.05.
Results
Case-control study results
Population characteristics. A total of 641 incident cases of
colorectal cancer and 1037 frequency-matched controls were
enrolled in this study. As shown in Table 1, males were 59.9%
rs961253 Variants and CRC Risk
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was 56.31 years (612.59) for cases and 57.24 years (610.86) for
controls. There was no significant difference in distribution of sex
(P=0.748) and age (P=0.119) between case and control group.
Association analysis. Table 2 displays the distribution of
rs961253 genotypes in cases and controls. Genotypes in controls
were in agreement with Hardy-Weinberg equilibrium (P=0.277).
Significant difference was observed in distribution of genotypes
between cases and controls (x
2=16.33, P,0.001). In multivariate
regression model, the carriers of the CA genotype showed a
significant increased CRC risk as compared with those carrying
the CC genotype (OR=1.56, 95%CI=1.21–2.01). Due to the low
frequency of the AA genotype in this study population, a dominant
model was perform, by combining the AA with the CA into an A
carrier (AA plus CA) group, to increase statistical power for
estimation of CRC risk. It was found that the A carriers have an
OR of 1.61 compared with carriers of the CC genotype (95%
CI=1.25–2.06). Additionally, significantly increased risk of CRC
was also found in additive model, with per-A-allele OR of 1.60
(95% CI=1.26–2.02).
Meta-analysis results
Study characteristics. As shown in Figure S1, 8 reports
were judged to preliminarily fit the inclusion criteria. After
detailed evaluation, 2 reports with incomplete data were removed
after contacting with authors by e-mail [29,30]. 3 reports shared
the same sample [5,31,32], of which, Tomlinson et al. [32] was
selected due to the largest sample, although Houlston et al. was the
first to suggest the association of rs961253 [5]. Finally, 4 reports
plus our case-control study comprising 17 studies of 29859 cases
and 29696 controls were included in this meta-analysis
[14,15,32,33]. Among these, 14 studies were conducted in
European and 3 in Asian (Table S1). Genotypes of rs961253 in
controls conformed to Hardy-Weinberg equilibrium for all
included studies (P.0.01).
Frequency of risk allele in control population. There was
significant heterogeneity in European group (P for heterogeneity
,0.001, I
2=71.1%). The pooled frequency of the A allele was
35.4% (95% CI=34.6%–36.2%) in European controls under
random-effects model, which was markedly higher than that of
8.1% in Asian controls without heterogeneity (95% CI=7.5%–
8.6%, P for heterogeneity=0.449; Figure S2).
Overall meta-analysis of rs961253 in associated with
CRC. In genotypic model, significant increased risk of CRC was
observed for the CA versus CC (OR=1.14, 95% CI=1.10–1.18;
Table 3) under fixed-effects model (P for heterogeneity=0.167). A
marginal heterogeneity was observed in the AA versus CC (P for
heterogeneity=0.102) as well as in dominant model (P for
heterogeneity=0.099), while significant heterogeneity was found
in additive model (P for heterogeneity=0.019). Therefore,
random-effects model was applied for the AA genotypic,
dominant and additive models, and all of these genetic models
conferred significant increased risk of CRC, with ORs of 1.25
(95% CI=1.16–1.34), 1.17 (95% CI=1.12–1.22), and 1.13 (95%
CI=1.09–1.18), respectively.
Meta-regression analysis and stratified analysis. To
explore potential sources of between-study heterogeneity under
additive model, meta-regression analysis was performed. A empty
regression was firstly run to estimate the baseline value for tau
2
(tau
2=0.0019), and then a series univariate model was conducted
by adding single covariates including ethnicity of population,
source of control, study type, sample size, and genotyping method.
In the univariate analysis, the model including ethnicity reduced
the tau
2 value to 0, and the adjusted R
2value was 100% (P=0.004),
suggesting ethnicity could totally explained the heterogeneity
across studies in additive model. Stratified analysis by ethnicity was
further performed. In European population, all genetic models
showed no evidence of heterogeneity (P for heterogeneity.0.1,
I
2=0), and present significantly increased risk of CRC, with ORs
of 1.12 (95% CI=1.08–1.16), 1.23 (95% CI=1.17–1.30), 1.14
(95% CI=1.10–1.18), and 1.11 (95% CI=1.08–1.14) for the
genotype CA versus CC, AA versus CC, and dominant and
additive models, respectively. In Asian population, only the
genotypic model of AA versus CC showed significant
heterogeneity (P for heterogeneity=0.012, I
2=77.2%). All
genetic models presented significant increased risk of CRC
except for the AA versus CC (Table 3). Additionally, larger
effect of the A variant was seen in Asian than that in European.
Sensitivity analysis. Since significant heterogeneity across
studies was observed for the additive model, we conducted a
sensitivity analysis to assess the effect of each study on the pooled
Table 1. The characteristics of the study population.
Variables
Cases (N=641)
No. (%)
Controls (N=1037)
No. (%) P
Sex 0.748
{
Males 384 (59.9) 613 (59.1)
Female 257 (40.1) 424 (40.9)
Age (years) 56.31612.59 57.24610.86 0.119
{
{P value was calculated by the x
2 test;
{P value was calculated by the t test.
doi:10.1371/journal.pone.0034625.t001
Table 2. Association between rs961253 and colorectal cancer risk in a Chinese population.
Genotype
Case (N=641)
No. (%)
Control (N=1037)
No. (%) P
{ Crude OR (95% CI) OR (95% CI)
{ P
{
CC 494 (77.1) 875 (84.5) ,0.001 1.00 1.00
CA 139 (21.7) 157 (15.1) 1.57 (1.22–2.03) 1.56 (1.21–2.01) 0.001
AA 8 (1.2) 4 (0.4) – – –
Dominant model – – 1.62 (1.26–2.08) 1.61 (1.25–2.06) ,0.001
Additive model – – 1.61 (1.27–2.04) 1.60 (1.26–2.02) ,0.001
Abbreviations: OR, Odds ratio; 95% CI, 95% confidence interval.
{P value was calculated by the x
2 test.
{Data were estimated by multivariate logistic regression model after adjusting for sex and age.
doi:10.1371/journal.pone.0034625.t002
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series of pooled OR with 95% CI produced repeatedly after
removal of each particular study continuously exceed 1.0, and the
pooled OR was similar before and after deletion of each study.
Similarly results were seen for other genetic models that no single
study meaningfully change the pooled ORs, indicating the robust
stability of the current results.
Cumulative meta-analysis. Cumulative analysis of the
association of rs961253 with CRC was conducted via the
assortment of studies by publication time. As shown in Figure 1,
inclinations toward significant association were evident over time
in all genetic models. Further, the 95% CIs became increasingly
narrower with each accumulation of more data, suggesting the
precision of the estimates was progressively boosted by continual
adding more sample.
Publication bias. As reflected by the funnel plot and the
Egger’s test, there was no publication bias in the genotypic models
of CA versus CC and AA versus CC and dominant model (P for
Egger’s test=0.269, 0.198, and 0.187, respectively), whereas a
marginally significant publication bias was seen in additive model
(P for Egger’s test=0.047). Then a trim-and-fill method was
implemented under random-effects model. Nevertheless, no
trimming was performed and pooled estimate was unchanged,
indicating our result was statistically robust.
Discussion
In this study, we found a significant association between
rs961253 and colorectal cancer in the Chinese population. Also,
the following meta-analysis pooling data from the current and 16
previously published studies indicated significant association of
rs961253 with CRC under genotypic, dominant and additive
models. Cumulative analysis further confirmed the significant
association, showing the effect of the variant became progressively
significant with each accumulation of more data over time. To best
our knowledge, this meta-analysis firstly combined published
GWA studies and replication studies to reflect a precision effect of
rs961253 on the CRC risk.
rs961253 is located at 20p12.3, a region bereft of genes or
predicted protein-encoding transcripts. However, BMP2 maps
342 kb telomeric to this locus [5], which is one of initiators of BMP
signaling by binding to its corresponding receptors. BMP signaling
can suppress the Wnt pathway to ensure a balanced control of
intestinal stem cell self-renewal [34]. As reflected by earlier studies,
mutations of BMP pathway have been described in juvenile
polyposis [35], an inherited syndrome that predisposes to CRC.
Recently, tumor suppression role of the BMP signaling has been
established, and the BMP pathway has been inactivated in up to
70% of sporadic CRC [36]. Considering all this information,
although no function report was concerning to the rs961253, it has
been speculated that this locus might alter the BMP signaling
transduction by the effect on BMP2 and thus affect CRC
incidence [37]. However, after the first GWA study concerning
Table 3. Meta-analysis of the rs961253 in association with colorectal cancer risk under different genetic models.
Variables Case/control Genetic model OR (95%CI) PI
2 (%) P for heterogeneity
Total (N=17) 29859/29696 CA versus CC 1.14 (1.10–1.18) ,0.001 24.9 0.167
AA versus CC 1.25 (1.16–1.34) ,0.001 31.8 0.102
Dominant model 1.17 (1.12–1.22) ,0.001 32.1 0.099
Additive model 1.13 (1.09–1.18) ,0.001 46.2 0.019
Ethnicity
European (N=14) 26220/25650 CA versus CC 1.12 (1.08–1.16) ,0.001 0.0 0.691
AA versus CC 1.23 (1.17–1.30) ,0.001 0.0 0.539
Dominant model 1.14 (1.10–1.18) ,0.001 0.0 0.555
Additive model 1.11 (1.08–1.14) ,0.001 0.0 0.471
Asian (N=3) 3639/4046 CA versus CC 1.37 (1.21–1.54) ,0.001 0.0 0.463
AA versus CC 1.63 (0.44–6.05) 0.465 77.2 0.012
Dominant model 1.39 (1.21–1.60) ,0.001 22.4 0.276
Additive model 1.34 (1.20–1.50) 0.001 53.5 0.116
doi:10.1371/journal.pone.0034625.t003
Table 4. Sensitivity analysis of additive model.
Omitted study OR (95% CI)
P for
heterogeneity I
2 (%)
Xiong, 2010 [32] 1.12 (1.08–1.16) 0.104 32.3
von Holst, 2010 [14] 1.14 (1.10–1.19) 0.025 45.5
Tomlinson,2011(UK1) [31] 1.14 (1.09–1.18) 0.013 49.5
Tomlinson, 2011(Scotland1) 1.13 (1.09–1.18) 0.013 49.5
Tomlinson, 2011(UK2) 1.14 (1.09–1.18) 0.013 49.5
Tomlinson, 2011(Scotland2) 1.13 (1.09–1.18) 0.016 48.3
Tomlinson, 2011 (VQ58) 1.14 (1.10–1.19) 0.027 44.8
Tomlinson, 2011 (CCFR) 1.14 (1.09–1.18) 0.015 48.8
Tomlinson, 2011 (Australia) 1.13 (1.09–1.18) 0.014 49.1
Tomlinson, 2011 (Helsinki) 1.13 (1.09–1.17) 0.020 46.9
Tomlinson, 2011 (Cambridge) 1.14 (1.10–1.19) 0.017 48.0
Tomlinson, 2011 (COIN/NBS) 1.14 (1.10–1.19) 0.034 43.3
Tomlinson, 2011 (UK3) 1.14 (1.09–1.19) 0.013 49.5
Tomlinson, 2011 (Scotland3) 1.13 (1.09–1.17) 0.025 45.4
Tomlinson, 2011 (UK4) 1.13 (1.09–1.18) 0.014 49.2
Ho, 2011 [13] 1.13 (1.09–1.18) 0.044 41.2
Zheng, 2011 1.12 (1.09–1.16) 0.150 27.2
doi:10.1371/journal.pone.0034625.t004
rs961253 Variants and CRC Risk
PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e34625rs961253, the follow-up replications have yielded inconsistent
results.
In this study, our data in the Chinese population indicated that
increased risk was significantly associated with the CA genotype
compared with the CC genotype, and similar significant
relationship maintained under the dominant and additive models.
For the AA genotype, due to the low frequency in this population,
we failed to estimate its precise effect. The following meta-analysis,
including 29859 cases and 29696 controls, provided a 100%
power for estimating the association between rs961253 and CRC.
Results indicated that all genetic models conferred significant
increased risk of CRC. However, although there was obvious
evidence of between-study heterogeneity for the additive models,
the heterogeneity had been totally explained by the ethnicity of
study population according to the result of meta-regression
analysis. Then stratified analysis by ethnicity was performed. In
European population, heterogeneity was removed, and all genetic
models of the A variant allele were still significantly associated with
increased risk, while all genetic models in Asian also conferred
increased risk without evidence of heterogeneity except for the AA
genotypic model. After compare male/female ratio, mean age and
MAF of risk allele, there were no significant finding between Asian
and European except MAF of risk allele. Therefore, the variance
of the AA genotypic effect between European and Asian may
attribute to different ethnic background characterized by allele
frequency difference, with pooled A allele frequencies of 35.4% in
European and of 8.1% in Asian. Additionally, ORs of genetic
models in Asian were all larger than those in European. In
consideration of the inverse relationship between allele frequency
and effect size based on purifying selection [38], we proposed that
the rs961253 variant might have larger effect in Asian than
European.
Figure 1. Forest plots of cumulative meta-analysis of rs961253 in association with colorectal cancer by published year under
different genetic models. (A) the CA versus CC; (B) the AA versus CC; (C) the dominant model; (D) the additive model.
doi:10.1371/journal.pone.0034625.g001
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in sensitivity analysis by showing that degree of heterogeneity was
reduced after exclusion of single study in Asian. In addition, no
single study influenced the overall ORs qualitatively for all genetic
models, suggesting the highly stability of the current results. The
cumulative analysis provided further support to the current results,
indicating that as accumulation of more data over time, the
precision of estimates was continuously enhanced and tendency
toward significant association was increasingly evident. Publication
bias was also comprehensively assessed in this current study. No
evidence of publication bias was found in all genetic models except
for the additive model as reflected by the funnel plot and Egger’s
test. We further applied trim-and-fill method to adjust for
publication bias. Nevertheless, result showed that meta-analysis
with or without the trim-and-fill method did not draw different
effect estimate. Taken together, the results of this meta-analysis are
sound and reliable.
Despite the clear strength of the current study yielding enough
power, some limitations should be addressed. CRC is a complex
trait caused by both genetic and environmental factors; however,
lacking of environment data limited our further evaluation of
gene-environment interaction. Although association between
rs961253 and CRC has been confirmed in this study, whether
this SNP is causal remained uncertain.
In conclusion, the results from our study in the Chinese
population and the meta-analysis combining different ethnicity
provided a more accurate depiction of the role of rs961253 in
CRC susceptibility, suggesting that the variant of rs961253 was
associated with increased risk of CRC, and the variant may
yielded larger effect on Asians than Europeans. However, fine-
mapping of 20p12.3 region or function analysis should be imposed
to identify causal variant.
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